Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
Alice L. Yu, M.D., Ph.D et al.,
N Engl J Med 2010; 363:1324-1334
פרוטוקולים
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
16:31
אין תגובות
Alice L. Yu, M.D., Ph.D. et al.
N Engl J Med 2010; 363:1324-1334
AEWS07P1 – A Pilot Study of Chemotherapy Intensification by Adding Vincristine, Topotecan and Cyclophosphamide to Standard Chemotherapy Agents with an Interval Compression Schedule in Newly Diagnosed Patients with Localized Ewing Sarcoma Family of Tumors
13:13
אין תגובות
STUDY CHAIR
Leo Mascarenhas, M.D.
Recent Advances in Neuroblastoma
16:49
אין תגובות
John M. Maris, M.D
N Engl J Med 2010; 362:2202-2211
AGCT0132 | A PHASE III STUDY OF REDUCED THERAPY IN THE TREATMENT OF CHILDREN WITH LOW AND INTERMEDIATE RISK EXTRACRANIAL GERM CELL TUMORS
12:29
אין תגובות
STUDY CHAIR: A. Lindsay Frazier, M.D., Sc.M.
EsPhALL: Amendment proposal
14:08
אין תגובות
An open-label study to evaluate the safety and efficacy
of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+
Neuroblastoma
16:09
אין תגובות
Natia Esiashvili MD, Cynthia Anderson MD, Howard M.Katzenstein MD
Current Problems in Cancer
Volume 33, Issue 6, November–December 2009, Pages 333-360
EsPhALL: EUDRACT-n° 2004-001647-30
14:14
אין תגובות
An open-label study to evaluate the safety and efficacy
of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+
NRSTS 2005 – a protocol for Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas
15:51
אין תגובות
EpSSG NRSTS 2005 protocol
Version 1.1
Radiotherapy Alone vs. Chemotherapy Followed by Response-based Radiotherapy for Newly Diagnosed Primary CNS Germinoma
15:36
אין תגובות
ACNS0232
A Phase III Group-Wide Study
STUDY CHAIR: Jeffrey C. Allen, M.D.
